AIResearchers introduce COMPASS, a pan-cancer AI foundation model trained on 10,000 tumor samples to predict immunotherapy responseThe model analyzes bulk tumor transcriptomes across 33 cancer types.3 Sources, 95d ago, first seen 95d agoCombined views78.1K3 Sources, first seen 95d ago408 likesCombined views78.1K3 Sources, first seen 95d ago408 likes
